Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing

被引:65
作者
Overhoff, Kirk A.
Moreno, Alejandro
Miller, Dave A.
Johnston, Keith P.
Williams, Robert O., III
机构
[1] Univ Texas, Coll Pharm, Austin, TX 78712 USA
[2] Univ Texas, Dept Chem Engn, Austin, TX 78712 USA
关键词
particle engineering; amorphous; supersaturation; nanoparticle; enteric polymer; dissolution model;
D O I
10.1016/j.ijpharm.2006.11.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The primary objective of the study is to investigate the influence of composition parameters including drug:polymer ratio and polymer type, and particle structure of enteric solid dispersions on the release of ITZ under sink and supersaturated dissolution conditions. Modulated differential scanning calorimetry (MDSC) was utilized to define the level of ITZ miscibility with each polymer. The compositions were completely miscible at 60% ITZ for both polymers and as high as 70% in HP-55. High potency composition glass transition temperatures (Tg) correlated with predicted Tg's from the Gordon-Taylor equation, however, recrystallization exotherms revealed pure amorphous regions indicating that phase separation occurred during particle formation. Furthermore, in vitro studies including X-ray powder diffraction (XRD), scanning electron microscopy (SEM), surface area analysis (BET), and dissolution were performed to determine differences between low potency (completely miscible) and high potency (partially miscible) compositions. Dissolution studies on low potency ITZ compositions revealed that miscibility plays an active role in ITZ release under sink conditions, and square root diffusion through the enteric polymer is observed. Supersaturated dissolution profiles revealed high potency compositions had maximum saturation levels (C/C-eqmax) between 10.6- and 8-times equilibrium solubility, but had higher cumulative extents of supersaturation, compared to low potency compositions which had C/C-eqmax values of 15-19.6. However, these low potency compositions rapidly precipitated leading to significantly lower AUCs (p < 0.05). The change in the miscibility of the solid dispersion had a pronounced effect of drug release (sink) while differences in potency influenced supersaturated dissolution profiles. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 36 条
[1]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[2]   The mechanisms of drug release from solid dispersions in water-soluble polymers [J].
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :131-144
[3]   Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method -: art. no. 68 [J].
Eerikäinen, H ;
Peltonen, L ;
Raula, J ;
Hirvonen, J ;
Kauppinen, EI .
AAPS PHARMSCITECH, 2004, 5 (04)
[4]   Polymeric drug nanoparticles prepared by an aerosol flow reactor method [J].
Eerikäinen, H ;
Kauppinen, EI ;
Kansikas, J .
PHARMACEUTICAL RESEARCH, 2004, 21 (01) :136-143
[5]  
FREI BL, 2003, INVESTIGATION PULMON
[6]   What is the true solubility advantage for amorphous pharmaceuticals? [J].
Hancock, BC ;
Parks, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (04) :397-404
[7]   SOLID DISPERSION OBTAINED FROM NIFEDIPINE AND ENTERIC COATING AGENT .1. DISSOLUTION BEHAVIOR [J].
HASEGAWA, A ;
NAKAGAWA, H ;
SUGIMOTO, I .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1984, 104 (05) :485-489
[8]  
HASEGAWA A, 1988, CHEM PHARM BULL, V36, P4941
[10]   In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis [J].
Hoeben, BJ ;
Burgess, DS ;
McConville, JT ;
Najvar, LK ;
Talbert, RL ;
Peters, JI ;
Wiederhold, NP ;
Frei, BL ;
Graybill, JR ;
Bocanegra, R ;
Overhoff, KA ;
Sinswat, P ;
Johnston, KP ;
Williams, RO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1552-1554